Art. -Nr.: HY-116514

(S)-(−)-Perillyl alcohol

Kundenbewertung

Based on 1 Customer Validation

(S)-(-)-Perillyl alcohol, a monoterpene, is an orally active farnesyl transferase and geranylgeranyl transferase inhibitor. (S)-(-)-Perillyl alcohol up-regulates the mannose-6-phosphate receptor, facilitating TGF-β1 activation and cytostasis,. (S)-(-)-Perillyl alcohol induces apoptosis in cancer cells, modulates cyclin D1 and AP-1 activity. (S)-(-)-Perillyl alcohol exhibits antitumor activity against sarcoma tumors in mice. (S)-(-)-Perillyl alcohol can be used for the research of squamous cell carcinoma of the esophagus and sarcoma 180.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Reinheit: 97.0%
CAS. Nr.: 18457-55-1
Formel: C₁₀H₁₆O
Molecular Weight:152.24

Speicherung:

4°C, stored under nitrogen

* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

(S)-(−)-Perillyl alcohol Chemical Structure

CAS. Nr.: 18457-55-1

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- Cellular Effect
- In Vitro
- In Vivo
Chemical Information
Lösungsmittel & Löslichkeit
- In Vitro
- In Vivo
Reinheit & Dokumentation
Verweise
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

Alle Endogenous Metabolite Isoform-spezifische Produkte anzeigen :

Cellular Effect

Cell Line	Type	Value	Description	References
A549	IC₅₀	>1000 μM Compound: POH	Cytotoxicity against human A549 cells after 72 hrs by MTT assay Cytotoxicity against human A549 cells after 72 hrs by MTT assay	[PMID: 23474907]
A549	IC₅₀	350 μM Compound: POH, (S)-Perillyl alcohol	Cytotoxicity against human A549 cells after 48 hrs by alamar blue assay Cytotoxicity against human A549 cells after 48 hrs by alamar blue assay	[PMID: 25121720]
Hs 683	IC₅₀	>1000 μM Compound: POH	Cytotoxicity against human Hs683 cells after 72 hrs by MTT assay Cytotoxicity against human Hs683 cells after 72 hrs by MTT assay	[PMID: 23474907]
MCF7	IC₅₀	>1000 μM Compound: POH	Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay	[PMID: 23474907]
PC-3	IC₅₀	>1000 μM Compound: POH	Cytotoxicity against human PC3 cells after 72 hrs by MTT assay Cytotoxicity against human PC3 cells after 72 hrs by MTT assay	[PMID: 23474907]
PC-3	IC₅₀	380 μM Compound: POH, (S)-Perillyl alcohol	Cytotoxicity against human PC3 cells after 48 hrs by alamar blue assay Cytotoxicity against human PC3 cells after 48 hrs by alamar blue assay	[PMID: 25121720]
SK-MEL-28	IC₅₀	>1000 μM Compound: POH	Cytotoxicity against human SK-MEL-28 cells after 72 hrs by MTT assay Cytotoxicity against human SK-MEL-28 cells after 72 hrs by MTT assay	[PMID: 23474907]
U-373MG ATCC	IC₅₀	>1000 μM Compound: POH	Cytotoxicity against human U373 cells after 72 hrs by MTT assay Cytotoxicity against human U373 cells after 72 hrs by MTT assay	[PMID: 23474907]

In Vitro

(S)-(-)-Perillyl alcohol exerts in vitro cytotoxic activity against human ovarian adenocarcinoma, colon carcinoma, and glioblastoma tumor cell lines^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Dietary (S)-(-)-Perillyl alcohol (POH) (0.5-1.0% dietary; ad libitum; daily for ~23 weeks) weakly promotes early esophageal tumorigenesis in N-nitrosomethylbenzylamine-treated male Fischer 344 rats, as shown by a significant increase in dysplastic lesions, while 1.0% (S)-(-)-Perillyl alcohol also causes a significant reduction in average tumor size without altering Ras membrane localization^[1].
Dietary 1.0% (S)-(-)-Perillyl alcohol (POH) (1.0% dietary; ad libitum; daily for ~25 weeks) causes transient food aversion and reduced body weight gain but no esophageal tumors or gross abnormalities in healthy male Fischer 344 rats over 25 weeks^[1].
(S)-(-)-Perillyl alcohol (100-200 mg/kg/day; i.p.; daily; 7 days) exhibits in vivo antitumor activity against Sarcoma 180 in Swiss mice, with tumor growth inhibition rates of 35.3% at 100 mg/kg/day and 45.4% at 200 mg/kg/day following 7 days of intraperitoneal administration^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Swiss mice (female, 25-30 g) injected with Sarcoma 18 cells^[2]
Dosage:

100 mg/kg/day; 200 mg/kg/day
Administration:

i.p.; daily; 7 days
Result:

Reduced mean tumor mass to 0.76 g, corresponding to a tumor growth inhibition rate of 35.3% (100 mg/kg/day dose).
Reduced mean tumor mass to 0.70 g, corresponding to a tumor growth inhibition rate of 45.4% (200 mg/kg/day dose).
Induced statistically significant tumor mass reductions compared to the negative control group at both doses.

Chemical Information

CAS. Nr. 18457-55-1
Appearance Liquid (Density: 0.96 g/cm³)
Molecular Weight 152.24
Formel C₁₀H₁₆O
Color Colorless to light yellow
SMILES

OCC1=CC[C@@H](C(C)=C)CC1
Structure Classification
- Terpenoids
- Other Monoterpenes
Initial Source
- Plants
- Labiatae
- Plants
- other families
- Endogenous metabolite
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

4°C, stored under nitrogen

* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

Lösungsmittel & Löslichkeit

In Vitro:

DMSO : ≥ 200 mg/mL (1313.72 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

* "≥" means soluble, but saturation unknown.

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

6.5686 mL

32.8429 mL

65.6858 mL

5 mM

1.3137 mL

6.5686 mL

13.1372 mL

10 mM

0.6569 mL

3.2843 mL

6.5686 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 5 mg/mL (32.84 mM); Clear solution

This protocol yields a clear solution of ≥ 5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)

Solubility: ≥ 5 mg/mL (32.84 mM); Clear solution

This protocol yields a clear solution of ≥ 5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil

Solubility: ≥ 5 mg/mL (32.84 mM); Clear solution

This protocol yields a clear solution of ≥ 5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

%
DMSO +

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
%
+
+
%
Tween-80 + +
%
Saline +

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Working solution concentration: 0.22 mg/mL

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (272 KB)
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Liston BW, et al. Perillyl alcohol as a chemopreventive agent in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Cancer Res. 2003 May 15;63(10):2399-403. [Content Brief]

[2]. Andrade LN, et al. In Vivo Anti-Tumor Activity and Toxicological Evaluations of Perillaldehyde 8,9-Epoxide, a Derivative of Perillyl Alcohol. Int J Mol Sci. 2016;17(1):32. Published 2016 Jan 4. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	6.5686 mL	32.8429 mL	65.6858 mL	164.2144 mL
	5 mM	1.3137 mL	6.5686 mL	13.1372 mL	32.8429 mL
	10 mM	0.6569 mL	3.2843 mL	6.5686 mL	16.4214 mL
	15 mM	0.4379 mL	2.1895 mL	4.3791 mL	10.9476 mL
	20 mM	0.3284 mL	1.6421 mL	3.2843 mL	8.2107 mL
	25 mM	0.2627 mL	1.3137 mL	2.6274 mL	6.5686 mL
	30 mM	0.2190 mL	1.0948 mL	2.1895 mL	5.4738 mL
	40 mM	0.1642 mL	0.8211 mL	1.6421 mL	4.1054 mL
	50 mM	0.1314 mL	0.6569 mL	1.3137 mL	3.2843 mL
	60 mM	0.1095 mL	0.5474 mL	1.0948 mL	2.7369 mL
	80 mM	0.0821 mL	0.4105 mL	0.8211 mL	2.0527 mL
	100 mM	0.0657 mL	0.3284 mL	0.6569 mL	1.6421 mL

Bioz

Keywords

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

(S)-(−)-Perillyl alcohol